Play all audios:
![Access through your institution Buy or subscribe Oral glucose gel is used to treat neonatal hypoglycemia (NH), an important health issue for newborns. Previously, our team reported the results of a laboratory study in which we measured the concentrations of two commonly used glucose gels, Glutose 15 and Insta-Glucose, and found percent differences of 39.6% to 79.6% depending on which part of the tube the dose was extracted from [1]. After we conducted the previous study, a new glucose gel, Sweet Cheeks (Dandle Lion Medical, Danbury, CT), became available. This product is neonate-specific and packaged in 3 mL syringes. There are no published studies on the glucose consistency in this new product even though many hospitals are using it as an alternative to the adult diabetes care products that we previously tested. We conducted a laboratory study in which we measured glucose concentrations in (i) aliquots taken from the top, middle, and bottom sections of 3 different lots of Sweet Cheeks, and in (ii) whole syringes from different lots of Sweet Cheeks. The glucose content in the gel was measured using hexokinase and glucose-6-phosphate dehydrogenase enzymes on the Siemens ADVIA 1800 analyzer (Siemens Healthcare Diagnostics, Inc., Tarrytown, NY) after first conducting a series of laboratory validation studies that determined that the analyzer accurately and precisely measured glucose in the gel substrate. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Stanzo K, Kumar V, Chiruvolu A, Cipher DJ. How much glucose is in the gel used to treat neonatal hypoglycemia? J Obstet Gynecol Neonatal Nurs. 2022;51:218–24. Article PubMed Google Scholar * Burakevych N, McKinlay C, Harris D, Alsweiler J, Harding J. Factors influencing glycaemic stability after neonatal hypoglycemia and relationship to neurodevelopmental outcome. Sci Rep. 2019;9:8132. Article PubMed PubMed Central Google Scholar Download references FUNDING Funding This study was funded by a grant received from the Baylor Scott and White Health Foundation. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Baylor Scott and White Health, 5252 West University Drive, McKinney, TX, 75071, USA Karen Stanzo * Quest Diagnostics | med fusion, Lewisville, TX, 75067, USA Vivek Kumar & Alice Gallegos * Baylor University Medical Center, Dallas, TX, USA Arpitha Chiruvolu * Pediatrix Medical Group of Dallas, Dallas, TX, USA Arpitha Chiruvolu Authors * Karen Stanzo View author publications You can also search for this author inPubMed Google Scholar * Vivek Kumar View author publications You can also search for this author inPubMed Google Scholar * Alice Gallegos View author publications You can also search for this author inPubMed Google Scholar * Arpitha Chiruvolu View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS KS was responsible for the original conception of the study, securing the funding, conducting the literature review, creating the discussion section and the reference list, and writing the final report. VK was responsible for designing the laboratory study and analyzing the data. AG performed the laboratory tests. AC assisted with funding procurement and provided feedback on the clinical implications of the findings. CORRESPONDING AUTHOR Correspondence to Karen Stanzo. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. RIGHTS AND PERMISSIONS Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Stanzo, K., Kumar, V., Gallegos, A. _et al._ How much glucose is in Sweet Cheeks oral glucose gel?. _J Perinatol_ 43, 1181–1182 (2023). https://doi.org/10.1038/s41372-023-01670-z Download citation * Received: 31 January 2023 * Revised: 22 March 2023 * Accepted: 28 March 2023 * Published: 06 April 2023 * Issue Date: September 2023 * DOI: https://doi.org/10.1038/s41372-023-01670-z SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative](data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>)
Access through your institution Buy or subscribe Oral glucose gel is used to treat neonatal hypoglycemia (NH), an important health issue for newborns. Previously, our team reported the
results of a laboratory study in which we measured the concentrations of two commonly used glucose gels, Glutose 15 and Insta-Glucose, and found percent differences of 39.6% to 79.6%
depending on which part of the tube the dose was extracted from [1]. After we conducted the previous study, a new glucose gel, Sweet Cheeks (Dandle Lion Medical, Danbury, CT), became
available. This product is neonate-specific and packaged in 3 mL syringes. There are no published studies on the glucose consistency in this new product even though many hospitals are using
it as an alternative to the adult diabetes care products that we previously tested. We conducted a laboratory study in which we measured glucose concentrations in (i) aliquots taken from the
top, middle, and bottom sections of 3 different lots of Sweet Cheeks, and in (ii) whole syringes from different lots of Sweet Cheeks. The glucose content in the gel was measured using
hexokinase and glucose-6-phosphate dehydrogenase enzymes on the Siemens ADVIA 1800 analyzer (Siemens Healthcare Diagnostics, Inc., Tarrytown, NY) after first conducting a series of
laboratory validation studies that determined that the analyzer accurately and precisely measured glucose in the gel substrate. This is a preview of subscription content, access via your
institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this
article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in
* Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Stanzo K, Kumar V, Chiruvolu A, Cipher DJ. How much glucose is in the gel used to treat
neonatal hypoglycemia? J Obstet Gynecol Neonatal Nurs. 2022;51:218–24. Article PubMed Google Scholar * Burakevych N, McKinlay C, Harris D, Alsweiler J, Harding J. Factors influencing
glycaemic stability after neonatal hypoglycemia and relationship to neurodevelopmental outcome. Sci Rep. 2019;9:8132. Article PubMed PubMed Central Google Scholar Download references
FUNDING Funding This study was funded by a grant received from the Baylor Scott and White Health Foundation. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Baylor Scott and White Health, 5252
West University Drive, McKinney, TX, 75071, USA Karen Stanzo * Quest Diagnostics | med fusion, Lewisville, TX, 75067, USA Vivek Kumar & Alice Gallegos * Baylor University Medical
Center, Dallas, TX, USA Arpitha Chiruvolu * Pediatrix Medical Group of Dallas, Dallas, TX, USA Arpitha Chiruvolu Authors * Karen Stanzo View author publications You can also search for this
author inPubMed Google Scholar * Vivek Kumar View author publications You can also search for this author inPubMed Google Scholar * Alice Gallegos View author publications You can also
search for this author inPubMed Google Scholar * Arpitha Chiruvolu View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS KS was responsible for
the original conception of the study, securing the funding, conducting the literature review, creating the discussion section and the reference list, and writing the final report. VK was
responsible for designing the laboratory study and analyzing the data. AG performed the laboratory tests. AC assisted with funding procurement and provided feedback on the clinical
implications of the findings. CORRESPONDING AUTHOR Correspondence to Karen Stanzo. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ADDITIONAL INFORMATION
PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. RIGHTS AND PERMISSIONS Springer Nature or its licensor
(e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted
manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Stanzo, K.,
Kumar, V., Gallegos, A. _et al._ How much glucose is in Sweet Cheeks oral glucose gel?. _J Perinatol_ 43, 1181–1182 (2023). https://doi.org/10.1038/s41372-023-01670-z Download citation *
Received: 31 January 2023 * Revised: 22 March 2023 * Accepted: 28 March 2023 * Published: 06 April 2023 * Issue Date: September 2023 * DOI: https://doi.org/10.1038/s41372-023-01670-z SHARE
THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to
clipboard Provided by the Springer Nature SharedIt content-sharing initiative